Vertex board adds former HHS official
Executive Summary
Vertex will nominate former HHS Assistant Secretary for Health Eve Slater, MD, to board of directors at annual meeting May 6. Slater served at HHS for a year after a 19-year career at Merck. She left HHS in February 2003 (1"The Pink Sheet" July 28, 2003, In Brief). Vertex also plans to nominate former Pfizer President-Global R&D John Niblack, PhD, to board. Niblack retired from Pfizer in 2002 (2"The Pink Sheet" Oct. 27, 2003, p. 20)...
You may also be interested in...
Pfizer Names LaMattina To Head R&D; Licensing Is “Corr” Function
Pfizer Global R&D President John LaMattina, PhD, will attempt to enhance the productivity of the largest pharmaceutical research operation in the world
President nominates HHS assistant secretaries
President Bush nominates HHS Principal Deputy Assistant Secretary Cristina Beato to be assistant secretary for health July 23. Beato would replace U.S. Surgeon General Richard Carmona, MD, who has been acting assistant secretary since Eve Slater, MD, resigned in February ("The Pink Sheet" Feb. 10, 2003, p. 10). Administration also names Senate Joint Economic Committee Senior Health Economist Michael O'Grady, PhD, to be HHS assistant secretary for planning & evaluation. O'Grady would replace former ASPE Bobby Jindal (1"The Pink Sheet" Feb. 17, 2003, In Brief)...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.